Kevin Charles Gorman - Net Worth and Insider Trading
Kevin Charles Gorman Net Worth
The estimated net worth of Kevin Charles Gorman is at least $72 Million dollars as of 2024-04-24. Kevin Charles Gorman is the CEO of Neurocrine Biosciences Inc and owns about 514,596 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $72 Million. Kevin Charles Gorman is also the Director of Xencor Inc and owns about 5,060 shares of Xencor Inc (XNCR) stock worth over $92,800. Details can be seen in Kevin Charles Gorman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin Charles Gorman has not made any transactions after 2024-02-13 and currently still holds the listed stock(s).
Transaction Summary of Kevin Charles Gorman
Kevin Charles Gorman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Charles Gorman owns 2 companies in total, including Neurocrine Biosciences Inc () , and Xencor Inc () .
Click here to see the complete history of Kevin Charles Gorman’s form 4 insider trades.
Insider Ownership Summary of Kevin Charles Gorman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Neurocrine Biosciences Inc | 2024-02-13 | Sr VP & Business Development | |
| Xencor Inc | 2024-02-13 | director |
Kevin Charles Gorman Latest Holdings Summary
Kevin Charles Gorman currently owns a total of 2 stocks. Among these stocks, Kevin Charles Gorman owns 514,596 shares of Neurocrine Biosciences Inc (NBIX) as of February 13, 2024, with a value of $72 Million and a weighting of 99.87%. Kevin Charles Gorman also owns 5,060 shares of Xencor Inc (XNCR) as of February 13, 2024, with a value of $92,800 and a weighting of 0.13%.
Latest Holdings of Kevin Charles Gorman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2024-02-13 | 514,596 | 140.25 | 72,172,089 |
| XNCR | Xencor Inc | 2024-02-13 | 5,060 | 18.34 | 92,800 |
Holding Weightings of Kevin Charles Gorman
Kevin Charles Gorman Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Charles Gorman has made a total of 16 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Neurocrine Biosciences Inc is the sale of 2,832 shares on February 13, 2024, which brought Kevin Charles Gorman around $376,713.
According to the SEC Form 4 filings, Kevin Charles Gorman has made a total of 1 transactions in Xencor Inc (XNCR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Xencor Inc is the acquisition of 53 shares on February 13, 2024, which cost Kevin Charles Gorman around $1,013.
Insider Trading History of Kevin Charles Gorman
- 1
Kevin Charles Gorman Trading Performance
GuruFocus tracks the stock performance after each of Kevin Charles Gorman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Charles Gorman is %. GuruFocus also compares Kevin Charles Gorman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Charles Gorman within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin Charles Gorman's insider trading performs compared to the benchmark.
Performance of Kevin Charles Gorman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.18 | |||||
| Relative Return to S&P 500(%) | 17.9 |
Kevin Charles Gorman Ownership Network
Ownership Network List of Kevin Charles Gorman
Ownership Network Relation of Kevin Charles Gorman
Kevin Charles Gorman Owned Company Details
What does Neurocrine Biosciences Inc do?
Who are the key executives at Neurocrine Biosciences Inc?
Kevin Charles Gorman is the Sr VP & Business Development of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Commerical Officer Eric Benevich , Chief Regulatory Officer Ingrid Delaet , and Chief Scientific Officer Jude Onyia .
Neurocrine Biosciences Inc () Insider Trades Summary
Over the past 18 months, Kevin Charles Gorman made 7 insider transaction in Neurocrine Biosciences Inc () with a net sale of 219,790. Other recent insider transactions involving Neurocrine Biosciences Inc () include a net sale of 281,301 shares made by Eric Benevich , a net sale of 95,706 shares made by Darin Lippoldt , and a net sale of 75,528 shares made by Julie Cooke .
In summary, during the past 3 months, insiders sold 323,755 shares of Neurocrine Biosciences Inc () in total and bought 0 shares, with a net sale of 323,755 shares. During the past 18 months, 1,247,725 shares of Neurocrine Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,247,725 shares.
Neurocrine Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurocrine Biosciences Inc Insider Transactions
Kevin Charles Gorman Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Charles Gorman. You might contact Kevin Charles Gorman via mailing address: 12790 El Camino Real, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
